1. Home
  2. APRE vs MTR Comparison

APRE vs MTR Comparison

Compare APRE & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • MTR
  • Stock Information
  • Founded
  • APRE 2006
  • MTR 1979
  • Country
  • APRE United States
  • MTR United States
  • Employees
  • APRE N/A
  • MTR N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • MTR Oil & Gas Production
  • Sector
  • APRE Health Care
  • MTR Energy
  • Exchange
  • APRE Nasdaq
  • MTR Nasdaq
  • Market Cap
  • APRE 10.0M
  • MTR 9.4M
  • IPO Year
  • APRE 2019
  • MTR N/A
  • Fundamental
  • Price
  • APRE $1.71
  • MTR $5.36
  • Analyst Decision
  • APRE Strong Buy
  • MTR
  • Analyst Count
  • APRE 2
  • MTR 0
  • Target Price
  • APRE $15.50
  • MTR N/A
  • AVG Volume (30 Days)
  • APRE 50.9K
  • MTR 169.9K
  • Earning Date
  • APRE 08-11-2025
  • MTR 01-01-0001
  • Dividend Yield
  • APRE N/A
  • MTR 3.93%
  • EPS Growth
  • APRE N/A
  • MTR N/A
  • EPS
  • APRE N/A
  • MTR 0.23
  • Revenue
  • APRE $1,284,475.00
  • MTR $668,826.00
  • Revenue This Year
  • APRE N/A
  • MTR N/A
  • Revenue Next Year
  • APRE N/A
  • MTR N/A
  • P/E Ratio
  • APRE N/A
  • MTR $23.67
  • Revenue Growth
  • APRE 33.27
  • MTR N/A
  • 52 Week Low
  • APRE $1.41
  • MTR $4.70
  • 52 Week High
  • APRE $5.01
  • MTR $10.42
  • Technical
  • Relative Strength Index (RSI)
  • APRE 52.34
  • MTR 48.03
  • Support Level
  • APRE $1.48
  • MTR $5.45
  • Resistance Level
  • APRE $1.91
  • MTR $10.42
  • Average True Range (ATR)
  • APRE 0.16
  • MTR 0.86
  • MACD
  • APRE -0.00
  • MTR -0.04
  • Stochastic Oscillator
  • APRE 63.14
  • MTR 8.17

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About MTR Mesa Royalty Trust

Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.

Share on Social Networks: